Earily Access Programs and
Name patients progroms
PatientsForce provides one-stop agency services for EAP/NPP.
PatientsForce, as a treatment access plateform,
conneect overseas distribution channels to support patients in Taiwan to access treatment while patients couldn’t access the drugs or treatment in Taiwan.
Are You Facing These Challenges?
In the face of clinical drug shortages or specialized treatment needs,
we understand your urgency and the administrative pressure involved.
Drug Shortages / Discontinued Supply
Disruptions in the original manufacturer’s supply chain or withdrawal from the Taiwan market can interrupt clinical treatments when no alternatives are available.
Complex Import Regulations
Navigating TFDA (Taiwan Food and Drug Administration) special import applications and hospital IRB (Institutional Review Board) reviews is time-consuming and administratively demanding.
Beyond Logistics
A Commitment to Comprehensive Patient Care
While traditional distributors focus solely on delivery, PatientsForce begins its true mission once the medicine is received. For every special import medicine requested through our platform, we provide a Dedicated Nurse Educator (NE) to offer a one-year patient support program.
Star via
LINE
1-Year Care Management Includes:
5 Simple Steps to Initiate Hope
Our team provides end-to-end guidance with a focus on data security and seamless documentation.
2
2. Patient
Evaluation
Confirm eligibility and drug feasibility
3
3. Document
Preparation
Assist physicians with TFDA documentation
4
4. TFDA
Approval
Special import application submission
Frequently Asked Questions (FAQ)
PatientsForce assists medical institutions in applying for special imports through the TFDA, strictly adhering to the Pharmaceutical Affairs Act and the Regulations for the Manufacture and Import of Specific Drugs for Special Approval. All medications are sourced from qualified original manufacturers or authorized distributors.
Timelines vary based on the case type (e.g., urgent shortage, rare disease, or new drug). The process includes hospital IRB review, TFDA approval, and international logistics. It typically ranges from several weeks to a few months. Our team provides full-process tracking.
Due to pharmaceutical advertising regulations and trade confidentiality, we do not publicize a product catalog. Please consult our licensed Case Managers via the LINE@ official account for professional inquiries and inventory checks.
